DOT-RNID-Header


Cambridge Healthtech Institute’s 12th annual conference on RNAi for Functional Genomics Screening will cover the latest in the use of RNA interference (RNAi) screens for identifying and validating drug targets and exploring unknown cellular pathways. It will cover everything from assay design to data analysis for the use of in vitro and in vivo siRNA (small interfering RNA) and shRNA (short hairpin RNA) screens, in a way that will evoke thought-provoking discussions and inspire collaborations. There is a growing interest in combining RNAi screens with gene editing, chemical genomics, overexpression studies and phenotypic screens, which will all be discussed here. There will be talks on how to best utilize such combination screens, while bringing in other RNA based screens which include microRNA (miRNA) and long non-coding RNA (LncRNA). Screening experts from pharma/biotech as well as from academic and government labs will share their experiences leveraging the utility of these diverse screening platforms for a wide range of applications. The conference will include oral presentations, posters, interactive panel discussions and technology workshops, where scientists can share best practices to figure out what works and what doesn’t and under what conditions.

Who should attend: Students, Post-Docs, Lab Technicians, Managers, Scientists, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Drug Discovery, Functional Screening, Compound Screening, High-Throughput Screening, Target ID and Validation, Hit-to-Lead Screening, Biomarker Discovery, Translational Research, Predictive Screening and Bioinformatics.

Topics will include, but are not limited to: 

  • siRNA versus shRNA screens; pooled versus arrayed screening
  • Genome-wide versus targeted screening
  • Assay choices and design for RNAi screening
  • Emerging applications for in vivo RNAi screening
  • Utilizing combination screening (RNAi and small molecule screens)
  • Complementing RNAi with gene editing and chemical genomics
  • RNAi for high-throughput phenotyping
  • Use of 3D cultures, co-cultures and organotypic cultures
  • Tackling off-target effects
  • Quality control, data analysis and standardization

If you are interested in speaking, click here to submit a speaking proposal.

The deadline for submission is March 11, 2015. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Tanuja Koppal, Ph.D.
Conference Director
Cambridge Healthtech Institute
E: tkoppal@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup
Sr. Business Development Manager
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

DOT Hub Icon 

2014 Discovery on Target Brochure  

2014 BROCHURE 

PREMIER SPONSOR 

Cellecta 

VIEW ALL SPONSORS 

VIEW MEDIA PARTNERS 


SPONSORSHIPS & EXHIBITS 

The exhibit hall was sold out in 2014, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2015, contact:

Jon Stroup
Sr. Business Development Manager
781-972-5483
jstroup@healthtech.com 


Westin Boston Waterfront

HOTEL & TRAVEL 

Westin Boston Waterfront
425 Summer Street
Boston, MA 02210
617.426.2000